Form 8-K BRISTOL MYERS SQUIBB CO For: Feb 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bristol-Myers Squibb Co. (BMY) PT Raised to $74 at BMO Capital
February 7, 2022 7:21 AM ESTBMO Capital analyst Evan David Seigerman raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $74.00 (from $72.00) while maintaining an Outperform rating.
The analyst commented, "Concerns around Revlimids erosion still overshadow the growth from the new product portfolio, but the... More
